- Home
- MCBS vs KURA Comparison
MCBS vs KURA Comparison
Compare MCBS & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCBS
- KURA
- Stock Information
- Founded
- MCBS 2006
- KURA 2014
- Country
- MCBS United States
- KURA United States
- Employees
- MCBS N/A
- KURA N/A
- Industry
- MCBS Major Banks
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MCBS Finance
- KURA Health Care
- Exchange
- MCBS Nasdaq
- KURA Nasdaq
- Market Cap
- MCBS 744.2M
- KURA 713.5M
- IPO Year
- MCBS 2019
- KURA N/A
- Fundamental
- Price
- MCBS $25.45
- KURA $10.26
- Analyst Decision
- MCBS Hold
- KURA Strong Buy
- Analyst Count
- MCBS 1
- KURA 13
- Target Price
- MCBS $31.00
- KURA $25.00
- AVG Volume (30 Days)
- MCBS 38.3K
- KURA 2.0M
- Earning Date
- MCBS 10-17-2025
- KURA 11-04-2025
- Dividend Yield
- MCBS 3.93%
- KURA N/A
- EPS Growth
- MCBS 11.15
- KURA N/A
- EPS
- MCBS 2.59
- KURA N/A
- Revenue
- MCBS $147,349,000.00
- KURA $83,279,000.00
- Revenue This Year
- MCBS $18.90
- KURA $68.63
- Revenue Next Year
- MCBS $27.50
- KURA $141.59
- P/E Ratio
- MCBS $9.83
- KURA N/A
- Revenue Growth
- MCBS 8.69
- KURA N/A
- 52 Week Low
- MCBS $24.24
- KURA $5.41
- 52 Week High
- MCBS $36.15
- KURA $19.73
- Technical
- Relative Strength Index (RSI)
- MCBS 33.92
- KURA 57.62
- Support Level
- MCBS $25.32
- KURA $10.18
- Resistance Level
- MCBS $26.64
- KURA $11.06
- Average True Range (ATR)
- MCBS 0.63
- KURA 0.58
- MACD
- MCBS -0.01
- KURA -0.02
- Stochastic Oscillator
- MCBS 6.40
- KURA 59.85
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.